Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

NCT04460326 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Treated With Insulin

Interventions

DRUG: Insulin glargine
DRUG: NovoLog
DRUG: Insulin Fiasp
OTHER: Standard carbohydrate diet

Sponsor

Boston Medical Center

Collaborators

[object Object]